Search
Coagulation Factor IX (Recombinant)
go.drugbank.com/drugs/DB00100ApprovedIt is not derived from human blood (unlike human Factor IX complex), and is instead produced by a genetically engineered Chinese hamster ovary (CHO) cell line that secretes recombinant Factor IX into cell … Recombinant Factor IX is indicated for the control and prevention of bleeding episodes in adult and pediatric patients with congenital factor IX deficiency (Hemophilia B).
Products: OCTANINE® F 500 UI, ALPROLIX® 500 UIAluminum chlorohydrex propylene glycol
go.drugbank.com/drugs/DB11208ApprovedIt is an antiperspirant active ingredient found in antiperspirant drug products for over-the-counter human use. … Aluminum chlorohydrex propylene glycol is a complex consisting of Aluminum Chorohydrate and propylene glycol (PG).
Products: 24 Hour Antiperspirant NaturalPlantago seed
go.drugbank.com/drugs/DB11097ApprovedInvestigationalIt is found in some laxatives for treating occasional constipation and restoring regularity in bowel movements. … Its potential benefit in maintaining remission in ulcerative colitis has been studied [A27156].
Categories: Herbs and Natural ProductsProducts: Fibre Three Powder 2.4 Gm/ 5.0 Gm, Karacil Pwr 50%Pazopanib
go.drugbank.com/drugs/DB06589ApprovedInvestigationalIt is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Categories: Heterocyclic Compounds, 2-Ring, Cytochrome P-450 SubstratesProducts: VOTRIENT 200 MG FİLM KAPLI TABLET, 30 ADET, VOPAZZİ 400 MG FİLM KAPLI TABLET, 60 ADETLysine
go.drugbank.com/drugs/DB00123ApprovedInvestigationalNutraceuticalLysine (abbreviated as Lys or K) is an α-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. This amino acid is an essential amino acid, which means that humans cannot synthesize it. … The ε-amino group acts as a site for hydrogen binding and a general base in catalysis.
Mixtures: VAMIN 14 EF ELEKTROLITSIZ AMINOASİT SOLÜSYON, 500 ML, POLİNUTHREE EN-550 ELEKTROLİTLİ AMİNOASİT ÇÖZELTİSİ, GLUKOZ ÇÖZELTİSİ, VE LİPİD EMÜLSİYONU, 1000 MLProducts: GNC L-Lysine 1000 TabletCarbimazole
go.drugbank.com/drugs/DB00389ApprovedAn imidazole antithyroid agent. Carbimazole is metabolized to methimazole, which is responsible for the antithyroid activity.
Synonyms: Ethyl 3-methyl-2-thioimidazoline-1-carboxylateProducts: CARBIMAZOLE 5 TABLET 5 mg, CAMAZOL TABLET 5 mgTolfenamic acid
go.drugbank.com/drugs/DB09216ApprovedTolfenamic acid, with the formula N-(2-methyl-3-chlorphenyl)-anthranilic acid, is a nonsteroidal anti-inflammatory agent. … [A31824] It was discovered by scientists at Medica Pharmaceutical Company in Finland. It is used in the UK as a treatment for migraine under the name of Clotam.
Categories: Non COX-2 selective NSAIDS, Cytochrome P-450 SubstratesProducts: TOLFEDINE TABLET 60 MG, TOLFEDINE TABLETS 6 MGBezafibrate
go.drugbank.com/drugs/DB01393ApprovedInvestigationalIt decreases low density lipoproteins and increases high density lipoproteins.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 InhibitorsSynonyms: 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acidFavipiravir
go.drugbank.com/drugs/DB12466ApprovedInvestigationalDiscovered by Toyama Chemical Co., Ltd. in Japan, favipiravir is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza. … [A191688,A191772,A191775] Not only does favipiravir inhibit replication of influenza A and B, but the drug has shown promise in the treatment of avian influenza, and may be an alternative option for
Categories: Cytochrome P-450 CYP2C8 Inhibitors, Cytochrome P-450 CYP2E1 InhibitorsProducts: KOVİPİR 200 MG FİLM KAPLI TABLET, 40 ADET, POLİCOVİR 200 MG FİLM KAPLI TABLET, 40 ADETExametazime
go.drugbank.com/drugs/DB11179ApprovedIt is used in the detection of altered regional cerebral perfusion and for the radiolabeling of autologous leukocytes. … It acts as a chelating agent for the radioisotope technetium-99m to form a cationic complex.
Products: CERETEC FOR INJECTION 0.5 mg/vial, CERETEC ESTABILIZADO KIT DE 500 MICROGRAMOS PARA PREPARACIÓN RADIOFARMACÉUTICA